Paediatric dysgerminoma: Results of three consecutive French germ cell tumours clinical studies (TGM-85/90/95) with late effects study

Browse the SEER Cancer Statistics Review 1975–2012 [Internet]. [cited 2016 Mar 25]. Available from: http://seer.cancer.gov/csr/1975_2012/browse_csr.php?sectionSEL=29&pageSEL=sect_29_table.01.html. Lacour, 2010, Incidence of childhood cancer in France: National Children Cancer Registries, 2000–2004, Eur J Cancer Prev, 19, 173, 10.1097/CEJ.0b013e32833876c0 Smith, 2006, Incidence and survival rates for female malignant germ cell tumors, Obstet Gynecol, 107, 1075, 10.1097/01.AOG.0000216004.22588.ce Terenziani, 2001, Childhood malignant ovarian germ cell tumors: a monoinstitutional experience, Gynecol Oncol, 81, 436, 10.1006/gyno.2001.6177 Norris, 1972, Relative frequency of ovarian neoplasms in children and adolescents, Cancer, 30, 713, 10.1002/1097-0142(197209)30:3<713::AID-CNCR2820300319>3.0.CO;2-G Martelli, 2003, Gonadal tumours in children, Arch Pediatr, 10, 246, 10.1016/S0929-693X(03)00038-1 Casey, 1996, Dysgerminoma: the role of conservative surgery, Gynecol Oncol, 63, 352, 10.1006/gyno.1996.0335 Teinturier, 1994, Pure dysgerminoma of the ovary in childhood: treatment results and sequelae, Med Pediatr Oncol, 23, 1, 10.1002/mpo.2950230102 Baranzelli, 1993, Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the ‘Société Française d'Oncologie Pédiatrique’ MGCT 1985–1989 study, Med Pediatr Oncol, 21, 395, 10.1002/mpo.2950210602 Fresneau, 2015, Sex-cord stromal tumors in children and teenagers: results of the TGM-95 study, Pediatr Blood Cancer, 62, 2114, 10.1002/pbc.25614 Baranzelli, 1999, Prognostic factors in children with localized malignant nonseminomatous germ cell tumors, J Clin Oncol, 17, 1212, 10.1200/JCO.1999.17.4.1212 De Corti, 2012, Prognosis of malignant sacrococcygeal germ cell tumours according to their natural history and surgical management, Surg Oncol, 21, e31, 10.1016/j.suronc.2012.03.001 Sudour-Bonnange, 2017, Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant), Pediatr Blood Cancer, 64, e26494, 10.1002/pbc.26494 Brock, 1991, Cisplatin ototoxicity in children: a practical grading system, Med Pediatr Oncol, 19, 295, 10.1002/mpo.2950190415 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Rothman, 1978, Estimation of confidence limits for the cumulative probability of survival in life table analysis, J Chronic Dis, 31, 557, 10.1016/0021-9681(78)90043-7 Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X El-Lamie, 2000, Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University, Eur J Gynaecol Oncol, 21, 605 Boran, 2005, Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas, Arch Gynecol Obstet, 271, 104, 10.1007/s00404-004-0601-6 Zanetta, 2001, Survival and reproductive function after treatment of malignant germ cell ovarian tumors, J Clin Oncol, 19, 1015, 10.1200/JCO.2001.19.4.1015 Dark, 1997, Surveillance policy for stage I ovarian germ cell tumors, J Clin Oncol, 15, 620, 10.1200/JCO.1997.15.2.620 Mann, 2000, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol, 18, 3809, 10.1200/JCO.2000.18.22.3809 Thomas, 1987, Current therapy for dysgerminoma of the ovary, Obstet Gynecol, 70, 268 Culine, 1995, Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave Roussy, Gynecol Oncol, 58, 344, 10.1006/gyno.1995.1240 Mitchell, 1991, The long-term effects of radiation therapy on patients with ovarian dysgerminoma, Cancer, 67, 1084, 10.1002/1097-0142(19910215)67:4<1084::AID-CNCR2820670436>3.0.CO;2-E Bekaii-Saab, 1999, Late relapse of ovarian dysgerminoma: case report and literature review, Gynecol Oncol, 72, 111, 10.1006/gyno.1998.5207 Jeyakumar, 2001, Late recurrence in ovarian dysgerminoma with successful response to standard adjuvant chemotherapy: a case report and review of the literature, Gynecol Oncol, 81, 314, 10.1006/gyno.2001.6135 Williams, 2004, Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group, Gynecol Oncol, 95, 496, 10.1016/j.ygyno.2004.07.044 Brewer, 1999, Outcome and reproductive function after chemotherapy for ovarian dysgerminoma, J Clin Oncol, 17, 2670, 10.1200/JCO.1999.17.9.2670 de Wit, 2007, Refining the optimal chemotherapy regimen in good prognosis germ cell cancer: interpretation of the current body of knowledge, J Clin Oncol, 25, 4346, 10.1200/JCO.2007.13.3777 Rogers, 2004, Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: a Pediatric Intergroup Study–Pediatric Oncology Group 9048 and Children's Cancer Group 8891, J Clin Oncol, 22, 3563, 10.1200/JCO.2004.01.006 Williams, 1991, Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group, J Clin Oncol, 9, 1950, 10.1200/JCO.1991.9.11.1950 Akyüz, 2000, Malignant ovarian tumors in children: 22 years of experience at a single institution, J Pediatr Hematol Oncol, 22, 422, 10.1097/00043426-200009000-00007 Pedersen-Bjergaard, 1991, Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours, Lancet, 338, 359, 10.1016/0140-6736(91)90490-G Le Deley, 2010, Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial, J Clin Oncol, 28, 3987, 10.1200/JCO.2010.28.5999 Gadner, 2001, A randomized trial of treatment for multisystem Langerhans' cell histiocytosis, J Pediatr, 138, 728, 10.1067/mpd.2001.111331 Tazi, 2017, Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study, Orphanet J Rare Dis, 12, 95, 10.1186/s13023-017-0651-z Solheim, 2015, Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the ‘cisplatin era’, Gynecol Oncol, 136, 224, 10.1016/j.ygyno.2014.12.010 Jiang, 2015, Gonadal malignancy in 202 female patients with disorders of sex development containing Y-chromosome material, Gynecol Endocrinol, 1 Jonson, 2010, Gonadal dysgenesis and gynecologic cancer, Obstet Gynecol, 116, 550, 10.1097/AOG.0b013e3181e4bfe9 Capito, 2011, Dysgerminoma and gonadal dysgenesis: the need for a new diagnosis tree for suspected ovarian tumours, J Pediatr Urol, 7, 367, 10.1016/j.jpurol.2011.02.021 Słowikowska-Hilczer, 2003, Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype, J Androl, 24, 270, 10.1002/j.1939-4640.2003.tb02672.x Cools, 2014, Managing the risk of germ cell tumourigenesis in disorders of sex development patients, Endocr Dev, 27, 185, 10.1159/000363642